2024-20895. Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Clozapine Test System  

  • Table 1—Clozapine Test System Risks and Mitigation Measures

    Identified risks to health Mitigation measures
    Incorrect test results Certain design verification and validation activities and Certain labeling information.
    ( print page 75491)
    Incorrect interpretation of test results Certain design verification and validation activities and Certain labeling information.

Document Information

Effective Date:
9/16/2024
Published:
09/16/2024
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final amendment; final order.
Document Number:
2024-20895
Dates:
This order is effective September 16, 2024. The classification was applicable on April 16, 2020.
Pages:
75489-75491 (3 pages)
Docket Numbers:
Docket No. FDA-2024-N-4058
Topics:
Medical devices
PDF File:
2024-20895.pdf
CFR: (1)
21 CFR 862